339662 <common-name>6-[1-(4-chlorophenyl)-3-[[2-(methoxycarbonylamino)phenyl]methoxy]pyrazolidin-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid</common-name> <description>6-[1-(4-chlorophenyl)-3-[[2-(methoxycarbonylamino)phenyl]methoxy]pyrazolidin-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid is a chemical compound with the formula C24H28ClN3O10. With an average molecular weight of 553.90 g/mol, 6-[1-(4-chlorophenyl)-3-[[2-(methoxycarbonylamino)phenyl]methoxy]pyrazolidin-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid is a heavy molecule.</description> <cas nil="true"/> <pubchem-id>139595841</pubchem-id> <chemical-formula>C24H28ClN3O10</chemical-formula> <weight>553.9</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-30T23:01:21Z</created-at> <updated-at type="dateTime">2026-08-30T23:01:21Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>COC(=O)NC1=CC=CC=C1COC2C(CN(N2)C3=CC=C(C=C3)Cl)OC4C(C(C(C(O4)C(=O)O)O)O)O</moldb-smiles> <moldb-formula>C24H28ClN3O10</moldb-formula> <moldb-inchi>InChI=1S/C24H28ClN3O10/c1-35-24(34)26-15-5-3-2-4-12(15)11-36-21-16(10-28(27-21)14-8-6-13(25)7-9-14)37-23-19(31)17(29)18(30)20(38-23)22(32)33/h2-9,16-21,23,27,29-31H,10-11H2,1H3,(H,26,34)(H,32,33)</moldb-inchi> <moldb-inchikey>KXGCEXAFMANOPU-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">553.1463218</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>-0.9</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM335555</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>6-[1-(4-chlorophenyl)-3-[[2-(methoxycarbonylamino)phenyl]methoxy]pyrazolidin-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organic oxygen compounds</superklass> <klass>Organooxygen compounds</klass> <subklass>Carbohydrates and carbohydrate conjugates</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0290080</sync-id> <structure-inchikey>KXGCEXAFMANOPU-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>80000000000000008000000000000000001000000000000000800040000000000000001000000020000000000000040000000000002000000000004000000000000200014000000000000000000000208000000003000000000010400000800000020100830000400000040008000000000201000000800000000000041000040000400200008000002000000000800000000001000000800000004000000000000000102000040002001c0000000000010004000000000100000000001000000000000000040000000000000000008010008000000000000202000000000000008040000000000040000000000440000000000000000000008004000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAmAAAAKQAAAIABBgBgAAAAAQMIACgAAAAD AgYAKAAAAAMECAAoAAAAAwIHAGgAAAADAgEGQCgAAAADBAZAaAAAAAMDAQZA aAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQZAKAAAAAMEBgBgAAAAAgIIACAA AAACBgBgAAAAAwEGAGAAAAADAQYAYAAAAAICBwAoAAAAAwMHAGAAAAACAQZA KAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQGgA AAADAwERACAAAAABCAAgAAAAAgYAYAAAAAMBBgBgAAAAAwEGAGAAAAADAQYA YAAAAAMBBgBgAAAAAwEIACAAAAACBgAoAAAAAwQIACgAAAADAggAaAAAAAMB AQgAYAAAAAEBCABgAAAAAQEIAGAAAAABAQsAAQABAiACAygCAgQgBAUgBQZo DAYHaAwHCGgMCAloDAkKaAwKCwALDAAMDQANDgAODwAPEAAQEQAQEiASE2gM ExRoDBQVaAwVFmgMFhdoDBUYAA4ZABkaABobABscABwdAB0eAB4fAB4gACAh KAIgIiAdIwAcJAAbJQAKBWgMEQ0AFxJoDB8aAEIEAAAABgUKCQgHBgUPDg0R EAYTFBUWFxIGGxwdHh8aFwQAAAAAAAAAFg== </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:40:06Z</structure-indexed-at> </compound>